MATRIXYL

Skin, Hair & CosmeticCosmetic

Solid evidence for a cosmetic peptide, though most data comes from company-sponsored studies rather than independent research. The single human trial showed measurable improvements in skin texture and wrinkle depth.

Primarily studied by cosmetic chemists and dermatological researchers investigating topical anti-aging treatments.

FDA Status
Research Only

Since Feb 2026

Evidence
Moderate
Studies

7 total, 1 human

What is MATRIXYL?

This synthetic peptide emerged from French cosmetic research in the 1990s as one of the first commercially successful anti-aging compounds. Found in premium skincare products from brands like Olay and L'Oréal, it represents the intersection of peptide science and mainstream cosmetics. The compound spawned several variations, including Matrixyl 3000 and Synthe'6, each targeting different aspects of skin aging.

The peptide works by tricking skin cells into thinking collagen has been damaged and needs repair. When applied topically, it binds to receptors on fibroblasts—the cells responsible for maintaining skin structure—and triggers a cascade of rebuilding activity. Think of it as sending a false alarm that prompts your skin to ramp up production of the proteins that keep it firm and elastic.

What the Research Shows

Seven studies total with only one human clinical trial, though that study was well-designed and showed statistically significant results over 12 weeks.

Notable Studies

Reported Benefits

Collagen synthesis
ECM production
Wrinkle reduction
Skin firmness1 study

Regulatory Status

Research OnlyEffective: Feb 2026

Last verified: Feb 2026

Related Peptides

This information is for research purposes only and does not constitute medical advice. Always consult a licensed physician before using any peptides.